BioSpace News Archive

Serenity Bioworks announces today it has completed the acquisition of DC-TAB, a recombinant human HspB5 that was previously in clinical development for relapse-remitting multiple sclerosis.

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, today announced project updates from its most advanced oncology program RVU120 and a selective PIM/FLT3 inhibitor SEL24 (MEN1703) will be made available at the 2022 ASCO Annual Meeting.

Boston Imaging, the United States headquarters of Samsung digital radiography and ultrasound systems, introduces the GM85 Fit, a new configuration of the premium AccE GM85; a digital radiography device featuring a user-centric design that aids in efficient and effective patient care.

Mr. Yaretz’ experience spans many industries including the development of industrial and medical imaging devices.

According to Report, the global asthma treatment market size is projected to reach around US$ 30.1 billion by 2027 from US$ 25.8 billion in 2021, growing at a CAGR of 2.6% from 2021 to 2027. Rising prevalence of asthma due to increasing levels of pollution is expected to augment the growth of the market.

The global biotechnology instruments market size is expected to surpass around US$ 107.5 billion by 2030 from valued at US$ 44.81 billion in 2021 and expanding growth at a CAGR of 10.2 % from 2021 to 2030.

According to industry experts, the global breast cancer diagnostics market is projected to register a CAGR of 7.3% from 2021 to 2030and to reach valuation of US$ 7.1 Bn by the end of 2030.

The global cancer biopsy market size was estimated at USD 25.54 billion in 2021 and is projected to reach USD 59.39 billion by 2030, growing at a CAGR of 17.6% from 2022 to 2030.

The global cancer therapeutics market size is projected to reach around US$ 335.06 billion by 2029 from US$ 166.5billion in 2021 and expanding growth at a CAGR of 9.1% from 2021 to 2030.

According to Precedence Research, the global drug discovery outsourcing market size is expected to surpass around US$ 6.12 billion by 2029 from valued at US$ 3.62 billion in 2021and it is estimated to expand at a CAGR of 6.8% from 2021 to 2030.